The shifting UK landscape surrounding entheogens is increasingly intricate, demanding careful assessment. While scientific inquiry into compounds like psilocybin and copyright continues to progress, and patient opportunity via private clinics is increasing, the legal framework remains uncertain. This presents a distinctive situation for both seeker